Autopsy report · NCT01382745

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

“low recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 10 years before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Dr. Te Vuong

Sponsor type

University, hospital or other

Conditions

Squamous Cell Carcinoma of Anal Canal

Interventions

Nimotuzumab; Intensity Modulated Radiation Therapy (IMRT)

Participants

1

Sites

1

Countries

Canada

Trials that died the same way

• Impact of Methadone on Prolonged Mechanical Ventilation in Patients on Continuous Treatment With Opioids
  “very low recruitment” (95% match in meaning)
• Study of Psychomotor Development and Attachment in Children Aged 6 to 30 Months With Oral Disorder
  “Recruitment too low” (92% match in meaning)
• Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
  “Poor recruitment” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.